# Gut Microbiome and Probiotics: What the Evidence Says
Canonical: https://www.migaku.app/guides/gut-microbiome-probiotics-evidence-review
Category: evidence-review
Summary: Gut Microbiome and Probiotics has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed 
Last reviewed: 2026-05-01
Reviewed by: Migaku Evidence Review
# Gut Microbiome and Probiotics: What the Evidence Says

## Quick Answer

Gut Microbiome and Probiotics has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Gut Microbiome, Probiotics and Bone: An Updated Mini Review | narrative review | 3 | 2019-02-15 | 10.3889/oamjms.2019.047 |
| Gut microbiome in alcohol-associated liver disease: interactions and therapeutic strategies | preclinical study | 4 | 2026-04-01 | 10.3389/fphar.2026.1770833 |

## What The Sources Report

- These bacteria have been found to modulate immune responses that are associated with many diseases such as Crohn's, irritable bowel syndrome, celiac, cardiovascular, and rheumatic. [Abboud Myriam (2019); evidence level 3]
- There is no convincing evidence of the role of GM in the development of bone formation and destruction. [Abboud Myriam (2019); evidence level 3]
- The incidence of alcohol-associated liver disease (ALD) has risen, making it a major cause of chronic liver disease. [Liang Xianting (2026); evidence level 4]
- Research on ALD gut microbiota reveals that pathobionts, includingand, increase in abundance, while beneficial bacteria such asanddecrease (;)The combination of gut barrier breakdown and microbial imbalance in the gut microbiota leads to increased liver damage in patients with ALD. [Liang Xianting (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For gut microbiome probiotics, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Abboud Myriam (2019). Gut Microbiome, Probiotics and Bone: An Updated Mini Review. DOI: 10.3889/oamjms.2019.047. PMCID: PMC6390135. PMID: 30834022. https://pmc.ncbi.nlm.nih.gov/articles/PMC6390135/
- Liang Xianting (2026). Gut microbiome in alcohol-associated liver disease: interactions and therapeutic strategies. DOI: 10.3389/fphar.2026.1770833. PMCID: PMC13079132. PMID: 41993584. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13079132/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.